Answers are grounded in this paper and cite their sources.
Objectives: The literature lacks sufficient data on the long-term side effects of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) when used for over a year.In this study, the frequency of potential side effects was investigated in patients with COPD who had been using ICS.Methods: This single-center and observational study included stable COPD patients diagnosed with spirometry who had been using ICS for at least 1 year.Patient demographic and clinical characteristics and ICS-related side effects were recorded in detail according to the hospital records.Results: The study enrolled 92 patients, 74 (80.4%) of whom were male, with an mean age of 66.5± 8.4 years.The frequency of potential side effects of ICS, including voice changes, oral candidiasis, bruises, and cataracts, was higher after treatment than before treatment (3 [3.3%] vs. 34 [36.9%],p<0.001; 3 [3.3%] vs. 15 [16.0%], p=0.008; 2 [2.2%] vs. 14 [15.2%],p=0.004; and 9 [9.8%] vs. 25 [27.2%],p=0.009, respectively).However, there was no difference in the frequency of adverse events such as pneumonia, mycobacterial infection, osteoporosis, and diabetes mellitus before and after treatment (20 [21.7%] vs. 19 [20.7%], p=0.860; 8 [8.7%] vs. 2 [2.2%], p=0.109; 4 [4.3%] vs. 8 [8.7%], p=0.388; and 10 [10.9%] vs. 13 [14.1%],p=0.678, respectively). Conclusion:Recognizing and assessing the side effects of ICS in patients with COPD and evaluating decisions regarding the use of ICS in routine clinical practice based on the benefit-risk ratio may be necessary.
No takes yet. Share an insight, caveat, or question.
Fatma Ceren Gürel (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: